Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

HighField Biopharma Starts China Trial of Immune Modulating Liposome for Glioma

publication date: Jul 18, 2023

Hangzhou HighField Biopharma, a clinical-stage immuno-oncology company employing immunoliposomes to treat cancer, has launched a China Phase Ib/II trial of HF1K16 for recurrent and refractory glioma. HF1K16 is a drug encapsulated immune-modulating liposome containing all-trans retinoic acid (ATRA), a small molecule metabolite of vitamin A. HighField develops next-gen drug-encapsulated immune-modulating liposomes and cancer-targeted immunoliposomes that promise to be less toxic and more effective than existing immune-oncology drugs. The liposome constructs are also more efficient, potentially lowering costs, the company says. More details.....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital